Using the Collaborative Institutional Training Initiative (CITI) Training Tools:
Instutitional Biosafety Committee
California State University, San Marcos (CSUSM) established an Institutional Biosafety Committee (IBC) under the authority of the Office of the President.
The policies of CSUSM follow guidelines and regulations set forth by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the United States Department of Agriculture (USDA), the Environmental Protection Agency (EPA) and the California Occupational Safety and Health Administration (Cal-OSHA).
The IBC establishes, monitors, and enforces CSUSM policies and procedures, which meet or exceed applicable norms or regulations for biohazardous materials and/or recombinant DNA.
Principal Investigators are responsible for ensuring IBC review of the following:
- Animal experiments requiring IBC approval with any of the above (prior to IACUC approval)
- Biological Toxins (Select Agent toxins below the permissible toxin amount)
- Human and Non-human Primate (NHP): blood, body fluids, tissues and primary or established cell lines
- Pathogens/Microorganisms: Risk Group 1 or higher
- Recombinant or Synthetic DNA work as defined by the NIH Guidelines
Most importantly, the IBC’s objective is to ensure that such activities meet standards of good biological safety practices, emphasizing protection of personnel, the public, and the environment.
CITI Information for IBC Members:
- Go to https://www.citiprogram.org/
- Register choosing Cal State San Marcos as your "Institution".
- Before completing any modules you must first choose a Learner Group.
- To view the instructions page for CSU San Marcos, look for the blue"i" in the upper right corner.
IBC Email Address
Messages are directed to the Office of Graduate Studies and Research and the IBC Chair.
Institutional Officer (IO)
Dr. Charles De Leone, Dean
Office of Graduate Studies and Research
National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
Centers for Disease Control and Prevention (CDC) Biosafety in Microbiological and Biomedical Laboratories